KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,036,000 | +6.6% | 62,331 | 0.0% | 0.50% | -11.7% |
| Q3 2020 | $1,910,000 | +88.0% | 62,331 | 0.0% | 0.57% | +67.0% |
| Q2 2020 | $1,016,000 | -27.4% | 62,331 | -55.7% | 0.34% | -42.3% |
| Q1 2020 | $1,400,000 | -23.1% | 140,705 | +6.3% | 0.59% | -8.3% |
| Q4 2019 | $1,820,000 | +0.9% | 132,344 | +8.2% | 0.64% | -6.7% |
| Q3 2019 | $1,804,000 | -10.8% | 122,273 | +19.6% | 0.69% | -7.3% |
| Q2 2019 | $2,022,000 | +9.8% | 102,198 | -25.3% | 0.74% | -9.2% |
| Q1 2019 | $1,841,000 | 0.0% | 136,767 | 0.0% | 0.82% | +3.7% |
| Q4 2018 | $1,841,000 | +9.5% | 136,767 | +41.9% | 0.79% | +36.4% |
| Q3 2018 | $1,681,000 | +0.8% | 96,352 | 0.0% | 0.58% | -6.3% |
| Q2 2018 | $1,667,000 | +11.5% | 96,352 | +20.8% | 0.62% | +0.2% |
| Q1 2018 | $1,495,000 | – | 79,752 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |